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Questionnaire: Mapping Research in AMR across the Joint Programming Countries
The purpose of this questionnaire is to collate comprehensive information on funded research in the area of AMR (antibacterial resistance) in humans, animals and the environment across the JPIAMR countries.
The JPIAMR Strategic Research Agenda (SRA) and this mapping exercise will be used to help prioritise areas for implementation across the Joint Programming Initiative.
Guidance
Include:
-Please collate data from all relevant public funding organisations in your country (research councils, the department of health, environment, rural affairs, etc., charities….) -Please include all research grant funding covering basic, applied and clinical research, including trials and epidemiological studies, public health and veterinary research relevant to AMR -Only research related to bacterial resistance should be included, not research on viruses, parasites, fungi, etc.
Exclude:
-Please exclude projects on basic bacteriology with no reference to bacterial resistance, antibiotic resistance, antibiotics, antibacterials in the title or abstract -Projects on generic (e.g. buildings) and research infrastructure (e.g. facilities, networks)
If there is anything you are unsure of, please submit the project for further investigation.
If information is not available for a given question, please state 'NA' (not available) and please explain why this is the case.
Priority topics identified in the draft Strategic Research Agenda are:
A Development of novel antibiotics and alternatives for antibiotics (drugs, biological, vaccines) -from basic research to the market B Design strategies to improve treatment and prevention of infections by developing new diagnostics C Global antibiotic resistance surveillance D Selection and transmission dynamics (biology and epidemiology) E The role of the environment and sewage as a source for the emergence and spread of antimicrobial resistance F Designing and testing Interventions to prevent acquisition, transmission and infection caused by antibioticresistant bacteria
If you have any questions, please contact the data analyst (details provided elsewhere). 
